Novel genetic predisposition to being overweight or obese identified

FHS
June 25, 2024
10:13 am

Researchers performed a case-control study to compare metabolic changes between individuals homozygous for a loss-of-function genetic variation in small integral membrane protein 1 (SMIM1) and the general population.

Researchers discover advances in predicting kidney failure in type 1 diabetes patients

In a paper published today in Science Translational Medicine, researchers from City of Hope, one of the largest cancer research and treatment organizations in the

May 23, 2024

Very Early ART Can Result in Sustained HIV Suppression in Neonates

In neonates with acquired in utero HIV infection, administration of antiretroviral therapy (ART) within 48 hours of life can lead to sustained HIV virological suppression

December 12, 2023

Mainz Biomed Announces Petra Smeltzer Starke to Join Company as Brand Ambassador – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 18.09.2024 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed

September 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.